Services

Strategic support across the non-dilutive funding process

Noradelis helps biotech companies make stronger funding decisions before, during, and after an SBIR/STTR submission. Engagements focus on funding fit, reviewer readiness, resubmission strategy, and scientific decision-making.

01

Funding fit & go/no-go assessment

Evaluate program fit, mechanism, eligibility, scientific maturity, competitive positioning, and whether the opportunity warrants your company’s time and resources.

Should this opportunity be pursued?

Explore the scope, deliverables, and engagement process.

Assess funding fit

02

Pre-submission review

An independent pre-submission review gives your team a reviewer-style assessment of scientific logic, positioning, likely reviewer questions, and major vulnerabilities while there is still time to revise.

Find weaknesses before submission.

Explore the scope, deliverables, and engagement process.

Explore pre-submission review

03

Summary-statement & resubmission strategy

Interpret reviewer feedback, distinguish fixable weaknesses from strategic problems, and decide whether to resubmit, redirect, or stop.

Turn reviewer feedback into a decision.

Explore the scope, deliverables, and engagement process.

Explore resubmission strategy

04

Strategic advisory

Ongoing scientific and strategic support for recurring funding decisions: which opportunities to pursue, when the company is ready, and how reviewer feedback should change the plan.

Build a stronger funding strategy over time.

Explore the scope, deliverables, and engagement process.

Explore strategic advisory

NIH SBIR/STTR strategy

Considering NIH funding? Explore our NIH SBIR/STTR consulting hub →

Your next funding decision

Discuss your funding strategy

Tell us what your company is pursuing, where you are in the process, and what decision or review you need help with.

Discuss your funding strategy